Concert Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-723
| Closed | -$269K | – | 382 |
|
|
2017
Q1 | $269K | Buy |
723
+3
| +0.4% | +$1.12K | 0.06% | 374 |
|
|
2016
Q4 | $267K | Sell |
720
-318
| -31% | -$118K | 0.06% | 378 |
|
|
2016
Q3 | $416K | Buy |
1,038
+102
| +11% | +$40.9K | 0.05% | 417 |
|
|
2016
Q2 | $325K | Buy |
936
+187
| +25% | +$64.9K | 0.04% | 433 |
|
|
2016
Q1 | $271K | Sell |
749
-79
| -10% | -$28.6K | 0.04% | 490 |
|
|
2015
Q4 | $450K | Buy |
828
+26
| +3% | +$14.1K | 0.06% | 379 |
|
|
2015
Q3 | $375K | Buy |
802
+15
| +2% | +$7.01K | 0.05% | 420 |
|
|
2015
Q2 | $402K | Buy |
787
+29
| +4% | +$14.8K | 0.05% | 410 |
|
|
2015
Q1 | $252K | Hold |
758
| – | – | 0.07% | 343 |
|
|
2014
Q4 | $312K | Buy |
758
+13
| +2% | +$5.35K | 0.05% | 448 |
|
|
2014
Q3 | $269K | Buy |
+745
| New | +$269K | 0.04% | 411 |
|